Sulforaphane Represses Matrix-Degrading Proteases and Protects Cartilage From Destruction In Vitro and In Vivo

OBJECTIVE: Sulforaphane (SFN) has been reported to regulate signaling pathways relevant to chronic diseases. The aim of this study was to investigate the impact of SFN treatment on signaling pathways in chondrocytes and to determine whether sulforaphane could block cartilage destruction in osteoarth...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Arthritis Rheum
Autors principals: Davidson, Rose K, Jupp, Orla, de Ferrars, Rachel, Kay, Colin D, Culley, Kirsty L, Norton, Rosemary, Driscoll, Clare, Vincent, Tonia L, Donell, Simon T, Bao, Yongping, Clark, Ian M
Format: Artigo
Idioma:Inglês
Publicat: BlackWell Publishing Ltd 2013
Matèries:
Cartilage Biology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4240673/
https://ncbi.nlm.nih.gov/pubmed/23983046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.38133
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars